Daytrading May 30 afternoon, page-77

NOV looking pretty darn interesting

Highlights:  Contract wins for the Technology Division.  Flexepin has gained strong market traction with commercial operations underway in Canada and Australia.  Cash on hand (excluding client funds) was at $5.6m at end of 3QFY16.  Total revenue in the nine months to 31 March 2016 of $4.1m, up 32% compared with $3.1m for entire FY15.  Novatti well funded to reach key commercial milestones as outlined in its December 2015 prospectus.  Group revenue will become more recurring in nature as the Company increases its SaaS and financial processing transaction revenues.  Management expects to announce significant updates for Flexepin and TransferBridge divisions in the short-term